Medicare Enrolled
Dr. Glenn Gmyrek, MD
Urology Physician · Fair Lawn, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gmyrek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gmyrek?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gmyrek
Dr. Glenn Gmyrek is an urology physician in Fair Lawn, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gmyrek performed 5,459 Medicare services across 3,218 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gmyrek received a total of $3,253 from 37 pharmaceutical and/or device companies across 193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gmyrek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 27% volume in NJ
$3,253 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,459
Medicare services
Top 27% in NJ for urology physician
3,218
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~273 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
1,361 | $3 | $14 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,185 | $74 | $247 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
844 | $9 | $35 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
420 | $8 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
288 | $105 | $357 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
276 | $51 | $196 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
149 | $133 | $537 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
145 | $216 | $715 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
143 | $152 | $572 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 142 | $131 | $728 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
91 | $31 | $107 |
| Simple change of bladder tube | 69 | $81 | $320 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
68 | $835 | $3,440 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
45 | $50 | $207 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
33 | $69 | $259 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $154 | $482 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
23 | $123 | $1,354 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
18 | $6 | $48 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
18 | $357 | $1,342 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
17 | $342 | $1,280 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
17 | $29 | $225 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
17 | $211 | $836 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
17 | $130 | $489 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
17 | $50 | $190 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
15 | $284 | $975 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
14 | $1,215 | $4,690 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
23.1% medium
75.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,253
Total received (2018-2024)
Avg $465/year across 7 years
Top 38% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
193
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,813 (86.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$440 (13.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$552
2023
$785
2022
$477
2021
$406
2020
$254
2019
$457
2018
$321
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$71
Teleflex LLC
$65
Janssen Biotech, Inc.
$65
Merck Sharp & Dohme LLC
$60
ABBVIE INC.
$57
Telix Pharmaceuticals
$55
Bayer Healthcare Pharmaceuticals Inc.
$28
Olympus America Inc.
$28
180 Medical, Inc.
$27
Boston Scientific Corporation
$25
COLOPLAST CORP
$24
PFIZER INC.
$17
Blue Earth Diagnostics Limited
$16
Ferring Pharmaceuticals Inc.
$14
Top 3 companies account for 36.3% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$672
Janssen Biotech, Inc.
$289
PFIZER INC.
$279
Teleflex LLC
$251
Bayer HealthCare Pharmaceuticals Inc.
$199
ABBVIE INC.
$117
Merck Sharp & Dohme LLC
$116
180 Medical, Inc.
$113
Bayer Healthcare Pharmaceuticals Inc.
$103
Telix Pharmaceuticals
$101
UROVANT SCIENCES INC
$83
Boston Scientific Corporation
$67
Janssen Products, LP
$60
Blue Earth Diagnostics Limited
$57
Antares Pharma, Inc.
$56
TOLMAR Pharmaceuticals, Inc.
$55
Dendreon Pharmaceuticals LLC
$51
Sumitomo Pharma America, Inc.
$49
Myovant Sciences Inc.
$49
Olympus America Inc.
$47
Axonics, Inc.
$42
NeoTract Inc.
$42
MEDIVATION FIELD SOLUTIONS LLC
$37
Allergan Inc.
$33
Tolmar, Inc.
$29
Merck Sharp & Dohme Corporation
$28
Progenics Pharmaceuticals, Inc.
$27
Ferring Pharmaceuticals Inc.
$27
Acerus Pharmaceuticals Corporation
$27
Kowa Pharmaceuticals America, Inc.
$25
Hollister Incorporated
$25
COLOPLAST CORP
$24
BOSTON SCIENTIFIC CORPORATION
$18
Verity Pharmaceuticals Inc.
$15
Amgen Inc.
$15
Endo Pharmaceuticals Inc.
$14
Clarus Therapeutics Inc.
$12
Top 3 companies account for 38.1% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · ILLUCCIX · JATENZO · KEYTRUDA · LUPRON DEPOT · MYRBETRIQ · Moses 550 DFL · Myrbetriq · Natesto · Nubeqa · ORGOVYX · OTREXUP · Onli · Otrexup · POSLUMA · PREMARIN · PROVENGE · PYLARIFY · Prolia · Rezum Generator · SEGLENTIS · Seglentis · TOVIAZ · Titan · Trelstar · UGN Laser Capital · UROLIFT · UroLift · VESICARE · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
684
Per 100K population
71.6
County median income
$123,715
Nearest hospital
VALLEY HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gmyrek is a clinical cardiology specialist, with above-average Medicare volume (top 27% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gmyrek experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Gmyrek performed 1,361 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gmyrek receive payments from pharmaceutical companies?
Yes. Dr. Gmyrek received a total of $3,253 from 37 companies across 193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gmyrek's costs compare to other urology physicians in Fair Lawn?
Dr. Gmyrek's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gmyrek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fair Lawn
Browse urology physicians in Fair Lawn ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology